Celegence Recognized on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Insights from Celegence CEO on The Benefits of Structured Data Use
01 Oct, 2024
The Benefits of Structured Data Use
In this article, Celegence CEO Sonia A. Veluchamy shares practical strategies for Medical Device organizations to get ahead of increased demands by improving efficiency in compliance. The article discusses the benefits of structured data use and why a smarter approach to regulated product information could pay operationally.
Article Highlights
- Maintaining patient safety and healthcare outcomes as device innovation accelerates
- Infusing Life Sciences technology such as GenAI and dedicated RIM and EIM systems to augment workloads
- Outsourcing expertise with AI enablement to complement in-house teams
- Driving a collaborative approach with content for efficiency end-to-end
Read the full article in Medical Product Outsourcing.
About Celegence
Celegence has proven experience with medical writing for regulatory submissions. Our deep regulatory expertise, combined with advanced AI-Enabled technology solutions, positions us uniquely to handle the complexities of medical writing. We ensure that every document is not only compliant but crafted to expedite approval processes and facilitate market access. For more information about our services can benefit your regulatory processes, contact us today.
Other Related Articles
28 Jul, 2025
20 Mar, 2025
11 Mar, 2025
07 Mar, 2025